ALBEX FUTURE LIMITED

💤Zombieactive
09563914 · ltd · incorporated 2015-04-28
Investment thesis
Zombie company — trading but stalled; unlikely mover.
Why interesting: Quiet, steady; could be a succession or carve-out candidate with the right conversation.
Why risky: No growth signal; thin margin for error on price.
🔒Estimated value
Upgrade to see
Turnover
year to Apr 2025
Net worth
£121.0k
book net assets
Opportunity
74/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: General medical practice activities
Sector: Human health & social work
ALSO REGISTERED FOR
  • 86220Specialist medical practice activities
  • 86900Other human health activities
Investor take
Pursue
Asset-holding vehicle with a 66-year-old founder — textbook succession opportunity.

Opportunity 74/100 (strong), bankability 75/100. Strong seller-intent signal (68/100, director aged 66). Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: share sale to pe / searcher (73/100).

Data confidence

Overall: medium (78/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile
address, 3 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
Confirmed no charges registered
85
Directors & officers
3 officers (1 active, 3 linked, 3 with DOB)
90
Ownership & PSC
1 active PSC(s) of 2 total, 2 with control declared
90
Director network
Network not yet resolved
30
Filing history
42 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
74/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
70
Active, clean filings, stable charge profile.
Acquirability
70
Strong succession / seller-readiness signals.
Risk profile
74
Few red flags.
Signal strength
90
Good data coverage for analysis.

Signals from accounts

Derived from iXBRL accounts · accounting standard not declared
Positive net assets
Net assets £121,025

Key financials

2 years extracted from filed iXBRL accounts
Cash
£121k
Net Worth
£121k
Current Assets
Current Liabilities
£0£24k£48k£73k£97k£121kApr 2024Apr 2025

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · accounting standard unknown
Metric2025-04-302024-04-30
Cash£120.9k
Net assets£121.0k
Average employees300

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

2 signals detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days
0
filings
Last 90 days
1
filing
  • 1 confirmation-statement
Last 180 days
2
filings
  • 1 confirmation-statement
  • 1 accounts
Counts from Companies House filing history.
Corporate timeline (26 events)Click to expand
  1. 2026-01-28
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  2. 2025-12-03
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  3. 2025-11-21
    📍
    change-sail-address-company-with-old-address-new-address
    address · AD02
  4. 2025-11-21
    📍
    change-registered-office-address-company-with-date-old-address-new-address
    address · AD01
  5. 2025-11-16
    📍
    change-sail-address-company-with-old-address-new-address
    address · AD02
  6. 2025-11-16
    📄
    cessation-of-a-person-with-significant-control
    persons-with-significant-control · PSC07
  7. 2025-11-16
    📄
    termination-director-company-with-name-termination-date
    officers · TM01
  8. 2025-11-16
    📄
    termination-director-company-with-name-termination-date
    officers · TM01
  9. 2025-11-14
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  10. 2025-11-14
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  11. 2025-11-14
    📍
    change-registered-office-address-company-with-date-old-address-new-address
    address · AD01
  12. 2025-11-01
    BELLON, Alexander Joseph resigned
    director
  13. 2025-11-01
    GRABARSKI, Jan resigned
    director
  14. 2025-01-31
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  15. 2024-04-29
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  16. 2023-03-14
    📄
    notification-of-a-person-with-significant-control
    persons-with-significant-control · PSC01
  17. 2023-03-14
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  18. 2023-03-14
    📄
    capital-allotment-shares
    capital · SH01
  19. 2023-01-24
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  20. 2022-03-03
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  21. 2021-07-21
    📄
    gazette-filings-brought-up-to-date
    gazette · DISS40
  22. 2021-07-20
    📄
    gazette-notice-compulsory
    gazette · GAZ1
  23. 2020-02-20
    BELLON, Alexander Joseph appointed
    director
  24. 2020-02-20
    GRABARSKI, Jan appointed
    director
  25. 2015-04-28
    🏢
    Company incorporated
    As ALBEX FUTURE LIMITED
  26. 2015-04-28
    GRABARSKA-KREISS, Beata Kamilla, Dr appointed
    director

Owner dependency

90/100
Critical — business is the founder

The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.

FACTORS
  • +Sole director: Only one active director — all governance concentrated on one person.
  • +Founder age: Director aged approximately 66 — succession pressure is live.

Succession & seller-readiness

70/100
Strong succession signal

Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.

SIGNALS
  • primaryFounder aged 63+: Senior director is approximately 66. Approaching typical UK retirement age — succession thinking likely.
  • primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
  • supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.

Red flags

1 med · 1 low
2 director resignations in last 12 months
medium

Multiple recent departures can indicate governance disagreement, succession event, or preparation for sale/stress.

Evidence: BELLON, Alexander Joseph resigned 2025-11-01; GRABARSKI, Jan resigned 2025-11-01

Multiple registered office changes
low

Multiple address changes in a short period can indicate operational instability or admin disorder.

Shareholders & ownership

1 active beneficial owner
NameSharesVoting rightsNature of controlNotified
Dr Beata Kreiss
Individual · British · DOB 10/1960 · age 66
2550%
25–50%25-50% shares · 25-50% voting06/04/2016
1 historic (ceased) PSC
  • Mr Jan Grabarskiceased 01/11/2025· 25-50% shares · 25-50% voting

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

Similar companies

Active · Healthcare & medical · CO postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
A25 SOLUTIONS LTD
12103393 · est 2019 · no financials extracted
6y
ABILITY PHYSIOTHERAPY LTD
12064200 · est 2019 · no financials extracted
6y
ACCA CONSULTANCY PRIVATE LIMITED
08960870 · est 2014 · no financials extracted
12y
ACORN AUTISM SPECIALISTS LIMITED
13511294 · est 2021 · no financials extracted
4y
ACP ASSESSMENTS AND CONSULTANCY LTD
16459586 · est 2025 · no financials extracted
ACTIVATE PROJECT CIC
16849644 · est 2025 · no financials extracted
AGOSTINHO LIMITED
14399311 · est 2022 · no financials extracted
3y
AHKA TOTAL CARE LTD
10136364 · est 2016 · no financials extracted
9y
AKOO LIMITED
11171594 · est 2018 · no financials extracted
8y
ALAN CRITCHLEY CONSULTING LTD
07571245 · est 2011 · no financials extracted
15y
ALBURJ MEDICAL SERVICES LIMITED
16092991 · est 2024 · no financials extracted
1y
ALI HEALTHCARE LIMITED
08100153 · est 2012 · no financials extracted
13y
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2015-04-28
Jurisdictionengland-wales
Primary SIC86210 — General medical practice activities

Registered office

1 The Atrium Phoenix Square
Wyncolls Road
Colchester
Essex
CO4 9AS
England

Filing status

Accounts
Next due: 2027-01-31
Last made up to: 2025-04-30
Confirmation statement
Next due: 2027-03-28
Last: 2026-03-14

Officers (1 active · 2 resigned)

GRABARSKA-KREISS, Beata Kamilla, Dr
director · ~66y · appointed 2015-04-28
View their other companies + combined net worth →
Active
BELLON, Alexander Joseph
director · ~34y · appointed 2020-02-20 · resigned 2025-11-01
Resigned
GRABARSKI, Jan
director · ~88y · appointed 2020-02-20 · resigned 2025-11-01
Resigned

Click a director name to see their full track record across all companies.

Recent filings (42 total)

confirmation-statement-with-updates
confirmation-statement · CS01
2026-04-14
accounts-with-accounts-type-total-exemption-full
accounts · AA
2026-01-28
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2025-12-03
change-sail-address-company-with-old-address-new-address
address · AD02
2025-11-21
change-registered-office-address-company-with-date-old-address-new-address
address · AD01
2025-11-21
change-sail-address-company-with-old-address-new-address
address · AD02
2025-11-16
cessation-of-a-person-with-significant-control
persons-with-significant-control · PSC07
2025-11-16
termination-director-company-with-name-termination-date
officers · TM01
2025-11-16
termination-director-company-with-name-termination-date
officers · TM01
2025-11-16
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2025-11-14
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2025-11-14
change-registered-office-address-company-with-date-old-address-new-address
address · AD01
2025-11-14
confirmation-statement-with-updates
confirmation-statement · CS01
2025-03-31
accounts-with-accounts-type-total-exemption-full
accounts · AA
2025-01-31
confirmation-statement-with-no-updates
confirmation-statement · CS01
2024-04-30